ETRM : Summary for EnteroMedics Inc. - Yahoo Finance

U.S. Markets closed

EnteroMedics Inc. (ETRM)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
5.64-0.01 (-0.18%)
At close: 4:00PM EDT

5.68 0.04 (0.71%)
After hours: 5:58PM EDT

People also watch
PULMIDXGBIOCXGTIGLBS
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close5.65
Open5.55
Bid5.68 x 100
Ask5.78 x 1200
Day's Range5.55 - 6.45
52 Week Range0.04 - 30.41
Volume1,717,164
Avg. Volume4,274,290
Market Cap38.77M
Beta2.66
PE Ratio (TTM)-0.15
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • EnteroMedics, Inc. :ETRM-US: Earnings Analysis: Q4, 2016 By the Numbers : March 16, 2017
    Capital Cube13 days ago

    EnteroMedics, Inc. :ETRM-US: Earnings Analysis: Q4, 2016 By the Numbers : March 16, 2017

    Categories: Yahoo Finance Get free summary analysis EnteroMedics, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of EnteroMedics, Inc. – LivaNova Plc, Boston Scientific Corporation, Misonix, Inc., NeuroMetrix, Inc., Natus Medical Incorporated, Johnson & Johnson, Medtronic plc and Abbott Laboratories (LIVN-US, BSX-US, MSON-US, NURO-US, BABY-US, JNJ-US, ... Read more (Read more...)

  • Zacks15 days ago

    Here's Why EnteroMedics (ETRM) Stock Soared Today

    Shares of EnteroMedics (ETRM) were up more than 10% in morning trading Tuesday after it was confirmed that the medical device company's new neuro-blocking obesity treatment will be featured on the daytime talk show The Doctors.

  • EnteroMedics' vBloc® Neurometabolic Therapy Featured on "The Doctors" TV Show
    PR Newswire16 days ago

    EnteroMedics' vBloc® Neurometabolic Therapy Featured on "The Doctors" TV Show

    ST. PAUL, Minn., March 13, 2017 /PRNewswire/ -- EnteroMedics Inc. (ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that its vBloc® Neurometabolic Therapy for the treatment of obesity will be featured on the March 14 episode of the Emmy Award-winning syndicated daytime talk show The Doctors. Frank Chae, MD, FACS, Chief Surgeon and Head of the Bariatric Center at Sky Ridge Medical Center in Colorado and Cindy Hudak, one of his patients who received vBloc Therapy will discuss the benefits of vBloc Therapy and Cindy's personal story of battling obesity.